Natalie C. Fisher

ORCID: 0000-0003-1769-7468
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Gene expression and cancer classification
  • Cancer Genomics and Diagnostics
  • Bioinformatics and Genomic Networks
  • Colorectal Cancer Treatments and Studies
  • Genetic factors in colorectal cancer
  • Single-cell and spatial transcriptomics
  • Cancer Immunotherapy and Biomarkers
  • Ferroptosis and cancer prognosis
  • Computational Drug Discovery Methods
  • Molecular Biology Techniques and Applications
  • Sphingolipid Metabolism and Signaling
  • Cell Image Analysis Techniques
  • Pancreatic and Hepatic Oncology Research
  • Liver Disease Diagnosis and Treatment
  • Cancer Research and Treatments
  • Esophageal Cancer Research and Treatment
  • Colorectal Cancer Screening and Detection
  • Radiomics and Machine Learning in Medical Imaging
  • Liver Disease and Transplantation
  • Colorectal Cancer Surgical Treatments
  • Genetic Associations and Epidemiology
  • Gastrointestinal Tumor Research and Treatment
  • Drug-Induced Hepatotoxicity and Protection
  • Calcium signaling and nucleotide metabolism
  • Autophagy in Disease and Therapy

Queen's University Belfast
2019-2025

Queens University
2024

Cancer Research UK
2022

Keele University
2013-2018

University of Michigan
2012-2018

Michigan Medicine
2013

James M. Chamberlain Jaideep Kapur Shlomo Shinnar Jordan Elm Maija Holsti and 95 more Lynn Babcock A. Rogers William G. Barsan James C. Cloyd Daniel H. Lowenstein Thomas P. Bleck Robin Conwit Caitlyn Meinzer Hannah R. Cock Nathan B. Fountain Ellen Underwood Jason T. Connor Robert Silbergleit Emily Gray Sonya A. Gunter Amy Fansler Valerie L. Stevenson Erin M. Bengelink Deneil Harney Mickie Speers Joy Black Natalie C. Fisher Donna Harsh Arthi Ramakrishnan Lindsey Harris Nia Bozeman Aimee Spiteri Amy Yu Holly Tillman Wenle Zhao Qi Pauls Chris Arnaud Catherine Dillon Jodie Riley T. C. Alford Cassidy Conner Lisa D. Coles Abhi Sathe Scott Janis Adam L. Hartman Brandy E. Fureman Eugen Trinka David M. Treiman David W. Wright Jonathan Ratcliff Alex Hall Alaina Williams Harold K. Simon Nicholas Stanley R. Humphries Theresa Mims Joann Short Elizabeth Jones Misty Ottman Nina T. Gentile Derek Isenberg Hannah Reimer V Kalugdan Claude Hemphill Debbie Y. Madhok Jeany Duncan Dominica Randazzo James Quinn Anita Visweswaran Rosen Mann Opeolu Adeoye Jason T. McMullan Brandon Foreman Sara Keegan Michelle H. Biros Brian E. Driver Audrey Hendrickson Jamie Stang Christopher Lewandowski Joseph Miller Kaleem Chaudhry Shannen Berry Craig R. Warden Rachel Blake Jennifer NB Cook Erin E. Sabolick Antoine Fermin Selman Katrina Kissman Monica Moore J. Stephen Huff Lea Becker Jan Claassen Ángela Velázquez Cristina Falo Zlatan Coralic Jackie Grupp-Phelan Jill M. Baren Angela M. Ellison Ashley L. Woodford Ima Samba

10.1016/s0140-6736(20)30611-5 article EN The Lancet 2020-03-20

Abstract Molecular stratification using gene-level transcriptional data has identified subtypes with distinctive genotypic and phenotypic traits, as exemplified by the consensus molecular (CMS) in colorectal cancer (CRC). Here, rather than data, we make use of gene ontology biological activation state information for initial class discovery. In doing so, defined three pathway-derived (PDS) CRC: PDS1 tumors, which are canonical/LGR5 + stem-rich, highly proliferative display good prognosis;...

10.1038/s41588-024-01654-5 article EN cc-by Nature Genetics 2024-02-13

OBJECTIVES: We aimed to understand and improve patient knowledge about self-management of cirrhosis. METHODS: gave 150 outpatients with cirrhosis a survey test disease knowledge. then them concise educational booklet and, 3 months later, follow-up survey. analyzed demographic clinical correlates baseline knowledge, compared scores before after the intervention. RESULTS: Only 53% 15 questions were answered correctly in The most commonly missed items related diet, such as sodium content sea...

10.1038/ajg.2012.214 article EN The American Journal of Gastroenterology 2013-03-01

Abstract Background Colorectal cancer (CRC) primary tumours are molecularly classified into four consensus molecular subtypes (CMS1–4). Genetically engineered mouse models aim to faithfully mimic the complexity of human cancers and, when appropriately aligned, represent ideal pre-clinical systems test new drug treatments. Despite its importance, dual-species classification has been limited by lack a reliable approach. Here we utilise, develop and set options for human-to-mouse CMS...

10.1038/s41416-023-02157-6 article EN cc-by British Journal of Cancer 2023-01-30

Abstract Purpose: Precise mechanism-based gene expression signatures (GES) have been developed in appropriate vitro and vivo model systems, to identify important cancer-related signaling processes. However, some GESs originally represent specific disease processes, primarily with an epithelial cell focus, are being applied heterogeneous tumor samples where the of genes signature may no longer be epithelial-specific. Therefore, unknowingly, even small changes stroma percentage can directly...

10.1158/1078-0432.ccr-22-1102 article EN cc-by Clinical Cancer Research 2022-07-06

Background: A small cluster of up to four cells, defined as tumour budding (TB), has been well studied an independent promising prognostic marker in CRC. However, its underlying mechanism CRC is unclear. Methods: Multi-omic approaches from bulk RNA regional GeoMx were used identify the TB and possible correlation with microenvironment tissue. The results validated using immunohistochemistry (IHC) multiplex immunofluorescence (mIF) staining. Results: Patients high have a worse outcome...

10.1101/2025.03.05.641608 preprint EN bioRxiv (Cold Spring Harbor Laboratory) 2025-03-07

Abstract Background: Bowel cancer screening has increased detection of colorectal precursors. Despite this incidence, while transcriptional characterisation and molecular subtyping approaches are well established in tumours, similar biological discovery polyps have been limited. While some multi-omics studies defined patterns aligned to serrated adenoma histological pathways, these generally performed small collections samples. This project aims define, for the first time, a comprehensive...

10.1158/1538-7445.am2025-6422 article EN Cancer Research 2025-04-21

Abstract Colorectal cancer (CRC) has been classified into molecular subtypes using gene-level data from both bulk and single-cell RNA sequencing (scRNA-seq), leading to the development of consensus (CMS) intrinsic CMS (iCMS). In addition CRC studies, scRNA-seq spatial transcriptomics characterization human polyps, aligned with conventional adenoma serrated identified distinct driver mutations, cells-of-origin iCMS traits associated each polyp type. These transcriptional classification...

10.1158/1538-7445.am2025-503 article EN Cancer Research 2025-04-21

Obatoclax belongs to a class of compounds known as BH3 mimetics which function antagonists Bcl-2 family apoptosis regulators. It has undergone extensive preclinical and clinical evaluation cancer therapeutic. Despite this, it is clear that obatoclax additional pharmacological effects contribute its cytotoxic activity. been claimed obatoclax, either alone or in combination with other molecularly targeted therapeutics, induces an autophagic form cell death. In addition, shown inhibit lysosomal...

10.1371/journal.pone.0150696 article EN cc-by PLoS ONE 2016-03-07

Bariatric surgery leads to changes in mental health, quality of life and social functioning, yet these outcomes differ among individuals. In this study, we explore patients' psychosocial experiences following bariatric elucidate the individual-level factors that may drive variation outcomes.Eleven semi-structured focus groups with Michigan Surgery Collaborative (MBSC) patients (n = 77). Interviews were audio recorded, transcribed verbatim, analyzed using a grounded theory approach. Data on...

10.1186/s40608-018-0215-3 article EN cc-by BMC Obesity 2018-10-15

Abstract Background Limited studies examine the immune landscape in Esophageal Adenocarcinoma (EAC). We aim to identify novel associations, which may inform immunotherapy treatment stratification. Methods Three hundred twenty-nine EAC cases were available Tissue Microarrays (TMA) format. A discovery cohort of 166 stained immunohistochemically for range adaptive (CD3, CD4, CD8 and CD45RO) checkpoint biomarkers (ICOS, IDO-1, PD-L1, PD-1). validation 163 was also accessed. digital pathology...

10.1186/s12885-020-06987-y article EN cc-by BMC Cancer 2020-06-01

Objective Stroma-rich tumours represent a poor prognostic subtype in stage II/III colon cancer (CC), with high relapse rates and limited response to standard adjuvant chemotherapy. Design To address the lack of efficacious therapeutic options for patients stroma-rich CC, we stratified our human tumour cohorts according stromal content, enabling identification biology underpinning potential vulnerabilities specifically within that could be exploited clinically. Following tumour-based...

10.1136/gutjnl-2021-326183 article EN cc-by Gut 2022-04-27

Abstract Molecular stratification, across many tumour types, has used gene-level transcriptional data to identify subtypes associated with distinct genotypes and biological traits, as exemplified by the consensus molecular (CMS), more recently intrinsic CMS (iCMS), in colorectal cancer. In an attempt develop that closely align cancer-relevant phenotypic traits KRAS mutant tumours, here we present approach uses gene ontology activation state information, rather than data, for initial stages...

10.21203/rs.3.rs-3891488/v1 preprint EN cc-by Research Square (Research Square) 2024-01-23

Tumour budding (TB) is an established prognostic feature in multiple cancers but not routinely assessed pathology practice. Efforts to standardise and automate assessment have shifted from haematoxylin eosin (H&E)-stained images towards cytokeratin immunohistochemistry. The aim of this study was compare manual H&E methods with a semi-automated approach built within QuPath open-source software.

10.1111/his.14574 article EN cc-by Histopathology 2021-09-28

Abstract The pro-tumourigenic role of epithelial TGFβ signalling in colorectal cancer (CRC) is controversial. Here, we identify a cohort born to be bad early-stage (T1) tumours, with aggressive features and propensity disseminate early, that are characterised by high cell-intrinsic signalling. In the presence concurrent Apc Kras mutations, activation rampantly accelerates tumourigenesis share transcriptional signatures those T1 human tumours predicts recurrence stage II CRC. Mechanistically,...

10.1038/s41467-022-35134-3 article EN cc-by Nature Communications 2022-12-07

Abstract Gene set enrichment analysis (GSEA) tools can identify biological insights within gene expression-based studies. Although their statistical performance has been compared, the downstream implications that arise when choosing between range of pairwise or single sample forms GSEA methods remain understudied. We compare and results obtained from various pre-ranking methods/options for GSEA, followed by a stand-alone comparison (ssGSEA) variation (GSVA). Pairwise fGSEA provide similar...

10.1038/s41598-024-80534-8 article EN cc-by Scientific Reports 2024-12-04

Autotaxin is an extracellular phospholipase D that catalyzes the hydrolysis of lysophosphatidyl choline (LPC) to bioactive lipid lysophosphatidic acid (LPA). LPA has been implicated in many pathological processes relevant cancer, including cell migration and invasion, proliferation, survival. The most potent autotaxin inhibitor described date analogue S32826 (IC50 5.6 nM). other inhibitors are notably lipophilic, creating a need improve their physical properties. Polymers becoming...

10.1021/ml4003106 article EN ACS Medicinal Chemistry Letters 2013-11-18

Introduction: Best practices dictate that biobanks ensure accurate determination of tumor content before supplying formalin-fixed, paraffin-embedded (FFPE) tissue samples to researchers for nucleic acid extraction and downstream molecular testing. It is advisable trained competent individuals, who understand the requirements tests, perform microscopic morphological examination. However, special skills, time, costs associated with these assessments can be prohibitive, especially in large case...

10.1089/bio.2020.0105 article EN Biopreservation and Biobanking 2021-03-29

Abstract BACKGROUND Colorectal cancer (CRC) primary tumours are molecularly classified into four consensus molecular subtypes (CMS1-4). Genetically engineered mouse models aim to faithfully mimic the complexity of human cancers and, when appropriately aligned, represent ideal pre-clinical systems test new drug treatments. Despite its importance, dual-species classification has been limited by lack a reliable approach. Here we utilise, develop and set options for human-to-mouse CMS...

10.1101/2022.06.17.496539 preprint EN cc-by bioRxiv (Cold Spring Harbor Laboratory) 2022-06-17

Autotaxin is an extracellular phospholipase D that catalyzes the hydrolysis of lysophosphatidyl choline (LPC) to generate bioactive lipid lysophosphatidic acid (LPA). has been implicated in many pathological processes relevant cancer. Intraperitoneal administration autotaxin inhibitor may benefit patients with ovarian cancer; however, low molecular mass compounds are known be rapidly cleared from peritoneal cavity. Icodextrin a polymer already clinical use because it slowly eliminated Herein...

10.1021/acs.jmedchem.8b00935 article EN Journal of Medicinal Chemistry 2018-07-30

Abstract Background Gene set enrichment analysis (GSEA) tools can be used to identify biological insights from transcriptional datasets and have become an integral within gene expression-based cancer studies. Over the years, additional methods of GSEA-based been developed, providing field with ever-expanding range options choose from. Although several studies compared statistical performance these tools, downstream implications that arise when choosing between pairwise or single sample forms...

10.1101/2024.03.15.585228 preprint EN cc-by bioRxiv (Cold Spring Harbor Laboratory) 2024-03-17
Coming Soon ...